Infection
Cephalosporins
β-Lactam antibiotics related to penicillins, more stable to many β-lactamases; later generations reach more gram-negative bacteria. Used for pyelonephritis, intra-abdominal and biliary infections and many others.
Mechanism of action
- Like penicillins, they bind penicillin-binding proteins and stop cell wall cross-linking.
- Each generation broadens activity against gram-negative bacteria: ceftriaxone and cefotaxime (third generation) reach Enterobacterales; ceftazidime and cefepime reach Pseudomonas.
- They do not cover enterococci or anaerobes well, so metronidazole is added for abdominal infections.
Molecular targets
- Penicillin-binding proteins: Irreversible inhibitor
Drugs in Cephalosporins
First generation
- Cefalexin (First generation, by mouth.)
Second generation
- Cefuroxime (Second generation.)
Third generation
- Ceftriaxone (Third generation; once daily.)
Fourth generation
- Cefepime (Fourth generation.)
Therapeutic uses
- Acute pyelonephritis and complicated urinary infection
- Acute appendicitis and cholecystitis, with metronidazole
- Pneumonia and meningitis (ceftriaxone)
- Infective endocarditis due to some streptococci (ceftriaxone)
Diseases it treats
Adverse effects
- Hypersensitivity
- Clostridioides difficile diarrhoea
- Biliary sludge (ceftriaxone)
Contraindications by condition
- Anaphylaxis to a penicillin (Contraindicated): Cross-reactivity is low but real; they are avoided after a severe immediate reaction.
- Ceftriaxone with intravenous calcium in newborns (Contraindicated): Calcium–ceftriaxone precipitates can form in the lungs and kidneys.
Connected topics
Written from
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 29, Cell Wall Inhibitors, Cephalosporins
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 43, Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics, Cephalosporins & cephamycins
Educational reference. Not medical advice, diagnosis or treatment.